Pressure change-mediated effects on vasoactive protein of endothelial cells in the flow field in vitro.
- Author:
Jia HU
1
;
Bengui ZHANG
;
Jiang WU
;
Eryong ZHANG
;
Weilin XU
;
Yingkang SHI
;
Yingqiang GUO
Author Information
1. Dept. of Thoracic & Cardiovascular Surgery, West China Hospital of Sichuan University, Chengdu 610041, China.
- Publication Type:Journal Article
- MeSH:
Cells, Cultured;
Cyclooxygenase 2;
genetics;
metabolism;
Endothelial Cells;
metabolism;
physiology;
Endothelin-1;
genetics;
metabolism;
Humans;
Nitric Oxide Synthase Type III;
genetics;
metabolism;
Pressure;
RNA, Messenger;
genetics;
metabolism;
Vascular Endothelial Growth Factor A;
genetics;
metabolism
- From:
Journal of Biomedical Engineering
2010;27(4):795-800
- CountryChina
- Language:Chinese
-
Abstract:
Lining the inner surface of the walls of blood vessels, Endothelial cells (ECs) go beyond providing selective membrane to maintain the natural structure and function of vessels; they also synthesize varieties of vasoactive proteins to modify the pressure shift in the local flow field and hence they adapt the physiological activities of vessels. In this experiment, ELISA and RT-PCR technologies were adopted. We set up five different pressure loaded ECs groups,one non-activated cultured ECs group and one single shear stress loaded ECs group. Such a design was intended to demonstrate the effects of pressure shift on the expression of vasoactive protein synthesized by ECs [Endothelin-1(ET-1), endothelial Nitric Oxide Synthase (eNOS), Cyclooxygenase-2(COX-2) and Vascular Endothelial Growth Factor(VEGF)]. Our aim was to elucidate the mechanism of the pressure shift mediated dysfunction in ECs and the related dose-effect relationship. Based on these data, we suggest that ECs could modify the expression of vasoactive protein for adapting to the pressure shift in the local flow field; while in the process of--40 cmH2O induced ECs' dysfunction, the vasoactive proteins eNOS, COX-2 and VEGF play an important role in protecting ECs.
